Delivery Order SPE2DB22D9239-SPE2DB24FDJ26
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $34,039.68 and has an ultimate completion date of July 19, 2024. The contract is for the delivery of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $45,572.70 and an ultimate completion date of March 17, 2025. The award is for the delivery of 4567394636 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The $25,529.76 contract is for the supply of 4564110226 PERJETA 420 MG/14 ML VIAL 14ML, with a performance period through April 16, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, valued up to $4,999,999 through 2025, which enables the agency to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm-fixed-price contract is for the delivery of 4564676682 - PERJETA 420 MG/14 ML VIAL 14ML and has a completion date of June 10, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, for the provision of a wide range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $25,529.76, is for the delivery of 4563651600 - PERJETA 420 MG/14 ML VIAL 14ML. This delivery order is issued under DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA, contract 4600082013 under the SPE2DB program, valued up to $4,999,999 through 2025. The IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,039.68 firm fixed-price contract is for the supply of 4566210981 PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,756.60 contract covers the delivery of 4556522685 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,114.54 contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML, with a period of performance through July 28, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $27,343.62 and a period of performance through February 19, 2025. It is for the procurement of 4567104411 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product, with a potential value of $8,509.92 and a completion date of February 23, 2024. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDJ26Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4564464595 ! PERJETA 420 MG/14 ML VIAL 14ML, with a ceiling value of $25,529.76 and a period of performance through May 20, 2024. The contract is not set aside and is awarded as a firm fixed price delivery order. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.5k | 4/29/24 |